This map shows the geographic impact of Dahlén Se's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dahlén Se with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dahlén Se more than expected).
This network shows the impact of papers produced by Dahlén Se. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dahlén Se. The network helps show where Dahlén Se may publish in the future.
Co-authorship network of co-authors of Dahlén Se
This figure shows the co-authorship network connecting the top 25 collaborators of Dahlén Se.
A scholar is included among the top collaborators of Dahlén Se based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Dahlén Se. Dahlén Se is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Knowles, Richard, Ratko Djukanović, PJ Sterk, et al.. (2016). Predictive performance of non-invasive Type 2 biomarkers for asthmatic sputum eosinophilia in Bobcat and U-Biopred studies. Spiral (Imperial College London).
Se, Dahlén, Barbro Dahlén, Maria Kumlin, et al.. (1994). Clinical and experimental studies of leukotrienes as mediators of airway obstruction in humans.. PubMed. 22. 155–66.6 indexed citations
11.
Jönsson, E., et al.. (1992). Lipoxin A4-induced release of thromboxane in the guinea-pig lung: studies of its characteristics using lipoxin A4-methyl ester.. PubMed. 5(3). 205–17.3 indexed citations
12.
Björck, T, Yoko Harada, Barbro Dahlén, et al.. (1991). Further evidence that leukotrienes are the major mediators of allergic constriction in human bronchi.. PubMed. 21A. 429–32.11 indexed citations
13.
Kumlin, Maria, T Björck, Mats Hámberg, et al.. (1991). 15(S)-hydroxyeicosatetraenoic acid (15-HETE) is the major arachidonic acid metabolite in human bronchi.. PubMed. 21A. 441–4.7 indexed citations
14.
Se, Dahlén, Barbro Dahlén, Erik Eliasson, et al.. (1991). Inhibition of allergic bronchoconstriction in asthmatics by the leukotriene-antagonist ICI-204,219.. PubMed. 21A. 461–4.26 indexed citations
15.
Se, Dahlén, T Björck, Maria Kumlin, Elisabeth Granström, & Per Hedqvist. (1990). Studies of leukotrienes as mediators in the human lung in vitro.. PubMed. 20. 193–200.6 indexed citations
16.
Hedqvist, Per, Johan Raud, & Dahlén Se. (1989). Dual action of prostaglandin E2 in allergic inflammation.. PubMed. 19. 539–42.6 indexed citations
17.
Se, Dahlén. (1989). Pharmacological activities of lipoxins and related compounds.. PubMed. 19. 122–7.3 indexed citations
18.
Hökfelt, Tomas, et al.. (1985). Evidence for leukotriene formation and a neuroendocrine role for leukotriene C4 in rat brain.. PubMed. 15. 561–4.3 indexed citations
19.
Se, Dahlén, et al.. (1985). Biosynthesis and biological activities of lipoxins.. PubMed. 15. 163–6.10 indexed citations
20.
Se, Dahlén. (1983). Pulmonary effects of leukotrienes.. PubMed. 512. 1–51.31 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.